MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $732,963 | +6008.0% | 3,173 | +1734.1% | 0.00% | – |
| Q2 2022 | $12,000 | -29.4% | 173 | +0.6% | 0.00% | – |
| Q1 2022 | $17,000 | +54.5% | 172 | +35.4% | 0.00% | – |
| Q4 2021 | $11,000 | +10.0% | 127 | +2.4% | 0.00% | – |
| Q3 2021 | $10,000 | -23.1% | 124 | -8.1% | 0.00% | – |
| Q2 2021 | $13,000 | +8.3% | 135 | +33.7% | 0.00% | – |
| Q1 2021 | $12,000 | +9.1% | 101 | +4.1% | 0.00% | – |
| Q4 2020 | $11,000 | -94.4% | 97 | -94.1% | 0.00% | -100.0% |
| Q3 2020 | $195,000 | +12.1% | 1,651 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $174,000 | +85.1% | 1,554 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $94,000 | -29.9% | 1,554 | 0.0% | 0.00% | -60.0% |
| Q3 2019 | $134,000 | -17.8% | 1,554 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $163,000 | +3975.0% | 1,554 | +3690.2% | 0.01% | – |
| Q1 2018 | $4,000 | -55.6% | 41 | -58.2% | 0.00% | -100.0% |
| Q4 2017 | $9,000 | – | 98 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
| Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
| ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
| HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
| Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
| EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
| GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
| SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
| ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |